{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T16:03:19Z","timestamp":1778947399140,"version":"3.51.4"},"reference-count":133,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s12350-021-02838-w","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T17:02:27Z","timestamp":1635958947000},"page":"2171-2187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Potential novel imaging targets of inflammation in cardiac sarcoidosis"],"prefix":"10.1016","volume":"29","author":[{"given":"Jakob","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan D.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-021-02838-w_bib1","first-page":"167","article-title":"Causes of death in patients with sarcoidosis: A morphologic study of 38 autopsies with clinicopathologic correlations","volume":"119","author":"Perry","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"10.1007\/s12350-021-02838-w_bib2","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1007\/s12350-021-02838-w_bib3","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s12350-017-0978-9","article-title":"Joint SNMMI\u2013ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"24","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02838-w_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12350-017-1043-4","article-title":"A joint procedural position statement on imaging in cardiac sarcoidosis: From the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American","volume":"25","author":"Slart","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02838-w_bib5","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jcmg.2019.01.011","article-title":"Repeatability and optimization of FDG positron emission tomography for evaluation of cardiac sarcoidosis","volume":"12","author":"Alvi","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib6","first-page":"1551","article-title":"FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models","volume":"42","author":"Mochizuki","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib7","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.115.166884","article-title":"Additional heparin preadministration improves cardiac glucose metabolism suppression over low-carbohydrate diet alone in 18F-FDG PET imaging","author":"Scholtens","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-016-0502-7","article-title":"Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation","volume":"24","author":"Osborne","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02838-w_bib9","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jcmg.2010.09.015","article-title":"Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis","volume":"3","author":"Tahara","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib10","first-page":"1989","article-title":"Usefulness of fasting 18 F-FDG PET in identification of cardiac sarcoidosis","volume":"45","author":"Okumura","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib11","first-page":"342","article-title":"Quantitative interpretation of FDG PET for cardiac sarcoidosis reclassifies visually interpreted exams and potentially impacts downstream interventions","volume":"35","author":"Varghese","year":"2018","journal-title":"Sarcoidosis Vasc Diffus Lung Dis"},{"key":"10.1007\/s12350-021-02838-w_bib12","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02838-w_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.112.000289","article-title":"Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by 18F-fluorodoexyglucose positron emission tomography?","author":"McArdle","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s12350-009-9110-0","article-title":"Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis","volume":"16","author":"Langah","year":"2009","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02838-w_bib15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12350-016-0490-7","article-title":"The response of FDG uptake to immunosuppressive treatment on FDG PET\/CT imaging for cardiac sarcoidosis","volume":"24","author":"Ahmadian","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02838-w_bib16","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-018-4195-9","article-title":"Use of 18 F-FDG PET\/CT texture analysis to diagnose cardiac sarcoidosis","author":"Manabe","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib17","first-page":"372","article-title":"Texture feature by FDG PET can predict events of cardiac sarcoidosis","volume":"60","author":"Manabe","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ijcard.2016.11.142","article-title":"Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis","volume":"228","author":"Shelke","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-021-02838-w_bib19","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s00259-018-4001-8","article-title":"Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET\/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia","volume":"45","author":"Muser","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib20","doi-asserted-by":"crossref","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02838-w_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/jcbfm.1983.1","article-title":"Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data","author":"Patlak","year":"1983","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1007\/s12350-021-02838-w_bib22","doi-asserted-by":"crossref","unstructured":"Karakatsanis NA, Trivieri MG, Abgral R, et al. Direct 4D Patlak 18F-FDG PET\/MR for the multi-parametric assessment of active cardiac sarcoidosis. In: 2017 IEEE nuclear science symposium and medical imaging conference, NSS\/MIC 2017\u2014Conference Proceedings. Institute of Electrical and Electronics Engineers Inc.; 2018. https:\/\/doi.org\/10.1109\/NSSMIC.2017.8532794.","DOI":"10.1109\/NSSMIC.2017.8532794"},{"key":"10.1007\/s12350-021-02838-w_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmg.2017.02.021","article-title":"Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis","author":"Dweck","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12149-018-1250-3","article-title":"Diagnostic value of quantitative assessment of cardiac 18F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis","volume":"32","author":"Lebasnier","year":"2018","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-82217-0","article-title":"Value of Patlak Ki images from 18F-FDG-PET\/CT for evaluation of the relationships between disease activity and clinical events in cardiac sarcoidosis","author":"Nakajo","year":"2021","journal-title":"Sci Rep"},{"key":"10.1007\/s12350-021-02838-w_bib26","article-title":"Somatostatin receptor imaging in active cardiac sarcoidosis: Would less be enough?","author":"Zubin Maslov","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02838-w_bib27","doi-asserted-by":"crossref","unstructured":"ten Bokum, Hofland, de Jong, et al. Immunohistochemical localization of somatostatin receptor sst2A in sarcoid granulomas. Eur J Clin Invest 1999;29:630-6. https:\/\/doi.org\/10.1046\/j.1365-2362.1999.00498.x.","DOI":"10.1046\/j.1365-2362.1999.00498.x"},{"key":"10.1007\/s12350-021-02838-w_bib28","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00259-011-1760-x","article-title":"68Ga-DOTATOC PET\/CT and somatostatin receptor (sst1\u2013sst5) expression in normal human tissue: Correlation of sst2 mRNA and SUVmax","volume":"38","author":"Boy","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/2191-219X-2-52","article-title":"68Ga-DOTATATE PET\/CT for the detection of inflammation of large arteries: Correlation with18F-FDG, calcium burden and risk factors","volume":"2","author":"Li","year":"2012","journal-title":"EJNMMI Res"},{"key":"10.1007\/s12350-021-02838-w_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2967\/jnumed.109.070672","article-title":"In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET\/CT: Correlation with coronary calcium burden and risk factors","volume":"51","author":"Rominger","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib31","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","article-title":"Detection of atherosclerotic inflammation by 68Ga-DOTATATE PET compared to [18F]FDG PET imaging","volume":"69","author":"Tarkin","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-021-02838-w_bib32","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-014-2884-6","article-title":"Targeting post-infarct inflammation by PET imaging: Comparison of 68Ga-citrate and 68Ga-DOTATATE with 18F-FDG in a mouse model","author":"Thackeray","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12149-016-1095-6","article-title":"The utility of PET\/CT with 68Ga-DOTATOC in sarcoidosis: Comparison with 67Ga-scintigraphy","volume":"30","author":"Nobashi","year":"2016","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib34","doi-asserted-by":"crossref","first-page":"77807","DOI":"10.18632\/oncotarget.12799","article-title":"Somatostatin receptor based PET\/CT in patients with the suspicion of cardiac sarcoidosis: An initial comparison to cardiac MRI","volume":"7","author":"Lapa","year":"2016","journal-title":"Oncotarget"},{"key":"10.1007\/s12350-021-02838-w_bib35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/j.semnuclmed.2011.02.001","article-title":"68Ga-labeled DOTA-peptides and 68Ga-labeled radiopharmaceuticals for positron emission tomography: Current status of research, clinical applications, and future perspectives","volume":"41","author":"Breeman","year":"2011","journal-title":"Semin Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib36","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-010-1512-3","article-title":"Procedure guidelines for PET\/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE","author":"Virgolini","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib37","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.112.114165","article-title":"Measured human dosimetry of 68Ga-DOTATATE","author":"Walker","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib38","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/MNM.0b013e32833f635e","article-title":"Distribution pattern of 68Ga-DOTATATE in disease-free patients","volume":"31","author":"Shastry","year":"2010","journal-title":"Nucl Med Commun"},{"key":"10.1007\/s12350-021-02838-w_bib39","unstructured":"Soultanidis G, Robson PM, Tsoumpas C, et al. Assessment of optimal circulation time for 68Ga-DOTATATE PET\/MR imaging of cardiac sarcoidosis: Preliminary data. J Nucl Med 2020. https:\/\/jnm.snmjournals.org\/content\/61\/supplement_1\/1338."},{"key":"10.1007\/s12350-021-02838-w_bib40","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2967\/jnumed.113.120600","article-title":"Comparative biodistribution and radiation dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in patients with neuroendocrine tumors","volume":"54","author":"Sandstr\u00f6m","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib41","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.2967\/jnumed.111.091165","article-title":"68Ga-DOTATOC versus 68Ga-DOTATATE PET\/CT in functional imaging of neuroendocrine tumors","volume":"52","author":"Poeppel","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib42","article-title":"Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study","author":"Bravo","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02838-w_bib43","doi-asserted-by":"crossref","DOI":"10.1007\/s11307-015-0873-1","article-title":"Comparison of somatostatin receptor 2-targeting PET tracers in the detection of mouse atherosclerotic plaques","author":"Rinne","year":"2016","journal-title":"Mol Imaging Biol"},{"key":"10.1007\/s12350-021-02838-w_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00259-007-0587-y","article-title":"68Ga-DOTANOC: Biodistribution and dosimetry in patients affected by neuroendocrine tumors","volume":"35","author":"Pettinato","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib45","first-page":"61","article-title":"Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: Characterization of uptake in normal organs and tumor lesions","volume":"54","author":"Prasad","year":"2010","journal-title":"QJ Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib46","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11307-010-0374-1","article-title":"68Ga-DOTA-NOC PET\/CT imaging of neuroendocrine tumors: Comparison with 111In-DTPA-octreotide (OctreoScan\u00ae)","volume":"13","author":"Krausz","year":"2011","journal-title":"Mol Imaging Biol"},{"key":"10.1007\/s12350-021-02838-w_bib47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13550-016-0207-6","article-title":"A dual tracer 68Ga-DOTANOC PET\/CT and 18F-FDG PET\/CT pilot study for detection of cardiac sarcoidosis","volume":"6","author":"Gormsen","year":"2016","journal-title":"EJNMMI Res"},{"key":"10.1007\/s12350-021-02838-w_bib48","doi-asserted-by":"crossref","DOI":"10.1097\/MNM.0000000000000869","article-title":"Gallium-68 DOTA-NOC PET\/CT as an alternate predictor of disease activity in sarcoidosis","author":"Sharma","year":"2018","journal-title":"Nucl Med Commun"},{"key":"10.1007\/s12350-021-02838-w_bib49","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00259-011-1935-5","article-title":"Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET\/CT for staging enteropancreatic neuroendocrine tumours","volume":"39","author":"Schreiter","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib50","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/ph13030038","article-title":"[68Ga]Ga-DOTA-TOC: The first FDA-approved 68Ga-radiopharmaceutical for PET imaging","volume":"13","author":"Hennrich","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1007\/s12350-021-02838-w_bib51","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s00259-012-2309-3","article-title":"68Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: Differentiation of physiological uptake and pathological processes in PET\/CT","volume":"40","author":"Kroiss","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib52","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s13139-018-0524-y","article-title":"Measurement of 68Ga-DOTATOC uptake in the thoracic aorta and its correlation with cardiovascular risk","volume":"52","author":"Lee","year":"2018","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib53","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00259-007-0450-1","article-title":"Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours","volume":"34","author":"Buchmann","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib54","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00259-012-2155-3","article-title":"Detection of cranial meningiomas: Comparison of 68Ga-DOTATOC PET\/CT and contrast-enhanced MRI","volume":"39","author":"Afshar-Oromieh","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ehf2.12243","article-title":"Cardiovascular magnetic resonance imaging and clinical performance of somatostatin receptor positron emission tomography in cardiac sarcoidosis","volume":"5","author":"Pizarro","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1007\/s12350-021-02838-w_bib56","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00259-009-1270-2","article-title":"Potential impact of 68Ga-DOTATOC PET\/CT on stereotactic radiotherapy planning of meningiomas","volume":"37","author":"Nyuyki","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib57","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00259-005-0063-5","article-title":"Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using68Ga-DOTATOC PET and comparison with 18F-FDG PET","volume":"33","author":"Dimitrakopoulou-Strauss","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib58","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijcard.2015.05.073","article-title":"Imaging of myocardial inflammation with somatostatin receptor based PET\/CT\u2014A comparison to cardiac MRI","volume":"194","author":"Lapa","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-021-02838-w_bib59","first-page":"1432","article-title":"PET imaging with 18F-FLT and thymidine analogs: Promise and pitfalls","volume":"44","author":"Shields","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib60","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00259-004-1687-6","article-title":"[18F]FLT-PET in oncology: Current status and opportunities","volume":"31","author":"Been","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib61","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.nucmedbio.2004.01.008","article-title":"Fully automated synthesis system of 3\u2032-deoxy-3\u2032-[18F]fluorothymidine","volume":"31","author":"Oh","year":"2004","journal-title":"Nucl Med Biol"},{"key":"10.1007\/s12350-021-02838-w_bib62","first-page":"1482","article-title":"18F-fluorothymidine radiation dosimetry in human PET imaging studies","volume":"44","author":"Vesselle","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib63","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.2967\/jnumed.110.077255","article-title":"Repeatability of metabolically active volume measurements with 18F-FDG and 18F-FLT PET in non-small cell lung cancer","volume":"51","author":"Frings","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib64","doi-asserted-by":"crossref","first-page":"690","DOI":"10.2967\/jnumed.110.084566","article-title":"Predictive value of initial18F-FLT uptake in patients with aggressive non-Hodgkin lymphoma receiving R-CHOP treatment","volume":"52","author":"Herrmann","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib65","first-page":"226","article-title":"18F-FLT PET for visualization of laryngeal cancer: Comparison with 18F-FDG PET","volume":"45","author":"Cobben","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib66","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.109.069310","article-title":"18F-FLT PET\/CT for early response monitoring and dose escalation in oropharyngeal tumors","author":"Troost","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib67","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1378\/chest.129.2.393","article-title":"Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography","volume":"129","author":"Yap","year":"2006","journal-title":"Chest"},{"key":"10.1007\/s12350-021-02838-w_bib68","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13550-017-0321-0","article-title":"Comparative evaluation of 18F-FLT and 18F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis","volume":"7","author":"Norikane","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1007\/s12350-021-02838-w_bib69","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1161\/CIRCRESAHA.115.307024","article-title":"Imaging macrophage and hematopoietic progenitor proliferation in atherosclerosis","volume":"117","author":"Ye","year":"2015","journal-title":"Circ Res"},{"key":"10.1007\/s12350-021-02838-w_bib70","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3892\/etm.2014.1687","article-title":"18F-FLT PET\/CT imaging in a Wister rabbit inflammation model","volume":"8","author":"Tan","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1007\/s12350-021-02838-w_bib71","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.nucmedbio.2009.03.009","article-title":"Comparison of 18F-FDG, 18F-FET and 18F-FLT for differentiation between tumor and inflammation in rats","volume":"36","author":"Lee","year":"2009","journal-title":"Nucl Med Biol"},{"key":"10.1007\/s12350-021-02838-w_bib72","doi-asserted-by":"crossref","DOI":"10.1097\/RLU.0b013e3181c7c149","article-title":"F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography\/computed tomography imaging in a case of neurosarcoidosis","author":"Kim","year":"2010","journal-title":"Clin Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib73","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12149-015-1047-6","article-title":"18F-FDG and18F-FLT PET\/CT imaging in the characterization of mediastinal lymph nodes","volume":"30","author":"Rayamajhi","year":"2015","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib74","doi-asserted-by":"crossref","DOI":"10.1097\/RLU.0000000000000653","article-title":"18F-FLT PET imaging in a patient with sarcoidosis with cardiac involvement","author":"Norikane","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib75","doi-asserted-by":"crossref","unstructured":"Martineau P, Pelletier-Galarneau M, Juneau D, Leung E, Nery P, DeKemp R, et al. FLT-PET for the assessment of sarcoidosis including cardiac and CNS involvement: Comparison to FDG-PET. J Nucl Med. http:\/\/jnm.snmjournals.org\/content\/60\/supplement_1\/226. Accessed 6 Apr 2020.","DOI":"10.1186\/s13550-020-00742-x"},{"key":"10.1007\/s12350-021-02838-w_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmg.2019.06.020","article-title":"Imaging cardiac sarcoidosis with FLT-PET compared with FDG\/perfusion-PET: A prospective pilot study","author":"Martineau","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib77","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jlcr.1483","article-title":"New method for routine production of l-[methyl-11C]methionine:in loop synthesis","volume":"51","author":"G\u00f3mez","year":"2008","journal-title":"J Label Compd Radiopharm"},{"key":"10.1007\/s12350-021-02838-w_bib78","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s002590050265","article-title":"Estimation of internal absorbed dose of l-[methyl-11C]methionine using whole-body positron emission tomography","volume":"25","author":"Deloar","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib79","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2967\/jnumed.107.048082","article-title":"Diagnostic accuracy of 11 C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy","volume":"49","author":"Terakawa","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib80","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12149-014-0931-9","article-title":"Comparison of 11C\u20134\u2032-thiothymidine, 11C-methionine, and 18F-FDG PET\/CT for the detection of active lesions of multiple myeloma","volume":"29","author":"Okasaki","year":"2015","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib81","first-page":"1160","article-title":"Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis","volume":"39","author":"Yamada","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib82","first-page":"1948","article-title":"18F-fluoro-l-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors","volume":"46","author":"Jacobs","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib83","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.2967\/jnumed.109.065904","article-title":"Methyl-l-11 C-methionine PET as a diagnostic marker for malignant progression in patients with glioma","volume":"50","author":"Ullrich","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib84","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.7150\/thno.15929","article-title":"Targeting amino acid metabolism for molecular imaging of inflammation early after myocardial infarction","volume":"6","author":"Thackeray","year":"2016","journal-title":"Theranostics"},{"key":"10.1007\/s12350-021-02838-w_bib85","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.112.112060","article-title":"14-Cmethionine uptake as a potential marker of inflammatory processes after myocardial ischemia and reperfusion","author":"Taki","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib86","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.116.174045","article-title":"11C-methionine PET of myocardial inflammation in a rat model of experimental autoimmune myocarditis","author":"Maya","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib87","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2967\/jnumed.107.044578","article-title":"Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: a comparison with 18F-FDG and 18F-FLT","volume":"49","author":"Zhao","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib88","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.rlu.0000222735.19513.bb","article-title":"Combined C-11 methionine and F-18 FDG PET imaging in a case of neurosarcoidosis","volume":"31","author":"Ng","year":"2006","journal-title":"Clin Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib89","doi-asserted-by":"crossref","DOI":"10.1097\/01.rlu.0000134997.91642.56","article-title":"C-11 methionine uptake in granulomatous disease","author":"Hain","year":"2004","journal-title":"Clin Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib90","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s12149-007-0142-8","article-title":"The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules\/masses when compared with 18F-FDG-PET","volume":"22","author":"Hsieh","year":"2008","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib91","doi-asserted-by":"crossref","DOI":"10.1186\/s41181-020-0091-2","article-title":"Fully-automated production of [68Ga]Ga-PentixaFor on the module Modular Lab-PharmTracer","author":"Spreckelmeyer","year":"2020","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1007\/s12350-021-02838-w_bib92","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2967\/jnumed.114.151647","article-title":"Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor","volume":"56","author":"Herrmann","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib93","article-title":"Accuracy of PET quantification in [68Ga]Ga-pentixafor PET\/MR imaging of carotid plaques","author":"Rausch","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02838-w_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13550-017-0294-z","article-title":"Response assessment with the CXCR4-directed positron emission tomography tracer [68Ga]pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavities","volume":"7","author":"Herhaus","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1007\/s12350-021-02838-w_bib95","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.116.179663","article-title":"Imaging the cytokine receptor CXCR4 in atherosclerotic plaques with the radiotracer 68Ga-Pentixafor for PET","author":"Hyafil","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib96","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2967\/jnumed.117.196485","article-title":"Clinical molecular imaging of chemokine receptor CXCR4 expression in atherosclerotic plaque using 68 Ga-pentixafor PET: Correlation with cardiovascular risk factors and calcified plaque burden","volume":"59","author":"Weiberg","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib97","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1007\/s00259-018-4076-2","article-title":"Imaging of chemokine receptor CXCR4 expression in culprit and nonculprit coronary atherosclerotic plaque using motion-corrected [68Ga]pentixafor PET\/CT","volume":"45","author":"Derlin","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmg.2015.09.008","article-title":"Molecular imaging of the chemokine receptor CXCR4 after acute myocardial infarction","author":"Thackeray","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmg.2018.01.001","article-title":"Imaging of C-X-C motif chemokine receptor CXCR4 expression after myocardial infarction with [68 Ga]pentixafor-PET\/CT in correlation with cardiac MRI","author":"Reiter","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib100","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1161\/CIRCULATIONAHA.105.583021","article-title":"Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling","volume":"112","author":"Su","year":"2005","journal-title":"Circulation"},{"key":"10.1007\/s12350-021-02838-w_bib101","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009055","article-title":"Application of hybrid matrix metalloproteinase-targeted and dynamic 201Tl single-photon emission computed tomography\/computed tomography imaging for evaluation of early post-myocardial infarction remodeling","author":"Thorn","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib102","first-page":"1640","article-title":"Early detection of doxorubicin-induced cardiotoxicity using the matrix metalloproteinase (MMP) targeted radiotracer, 99mTc-RP805","volume":"57","author":"Boutagy","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib103","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2967\/jnumed.114.152355","article-title":"Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease","volume":"56","author":"Jung","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib104","doi-asserted-by":"crossref","first-page":"94969","DOI":"10.18632\/oncotarget.21662","article-title":"18F-fluoromisonidazole in tumor hypoxia imaging","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1007\/s12350-021-02838-w_bib105","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.semnuclmed.2007.07.001","article-title":"Hypoxia positron emission tomography imaging with 18F-fluoromisonidazole","volume":"37","author":"Lee","year":"2007","journal-title":"Semin Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib106","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.nucmedbio.2005.06.003","article-title":"Fully automated synthesis of [18F]fluoromisonidazole using a conventional [18F]FDG module","volume":"32","author":"Oh","year":"2005","journal-title":"Nucl Med Biol"},{"key":"10.1007\/s12350-021-02838-w_bib107","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0360-3016(92)91001-4","article-title":"Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole","volume":"22","author":"Koh","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1007\/s12350-021-02838-w_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13550-019-0525-6","article-title":"Biodistribution and radiation dosimetry of the novel hypoxia PET probe [18F]DiFA and comparison with [18F]FMISO","volume":"9","author":"Watanabe","year":"2019","journal-title":"EJNMMI Res"},{"key":"10.1007\/s12350-021-02838-w_bib109","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s00259-016-3320-x","article-title":"18F-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumors","volume":"43","author":"Toyonaga","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib110","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-014-2810-y","article-title":"Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma","author":"Sato","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib111","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1212\/WNL.51.6.1617","article-title":"Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole","volume":"51","author":"Read","year":"1998","journal-title":"Neurology"},{"key":"10.1007\/s12350-021-02838-w_bib112","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/thoraxjnl-2015-207402","article-title":"Hypoxia and tissue destruction in pulmonary TB","volume":"71","author":"Belton","year":"2016","journal-title":"Thorax"},{"key":"10.1007\/s12350-021-02838-w_bib113","first-page":"1103","article-title":"Hyoxia imaging with 18F-fluoromisonidazole (FMISO) for differentiating tumors from granulomas: A comparison with FDG in experimental rat models using small animal PET","volume":"51","author":"Zhao","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib114","doi-asserted-by":"crossref","DOI":"10.1007\/s12350-016-0495-2","article-title":"18F-fluoromisonidazole (FMISO) PET may have the potential to detect cardiac sarcoidosis","author":"Manabe","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02838-w_bib115","article-title":"18F-FMISO PET\/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis","author":"Furuya","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02838-w_bib116","first-page":"692","article-title":"Reduction-mediated technetium-99m labeling of monoclonal antibodies","volume":"31","author":"Mather","year":"1990","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib117","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/401341","article-title":"In vivo evaluation of TNF-alpha in the lungs of patients affected by sarcoidosis","author":"Galli","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1007\/s12350-021-02838-w_bib118","first-page":"1","article-title":"Overview of 99mTc-anti-TNF-α scintigraphy: Diagnostic applications","volume":"7","author":"Yalcin","year":"2013","journal-title":"Rep Med Imaging"},{"key":"10.1007\/s12350-021-02838-w_bib119","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1093\/rheumatology\/ker234","article-title":"99mTc-anti-TNF-scintigraphy in RA: A comparison pilot study with MRI and clinical examination","volume":"50","author":"Roimicher","year":"2011","journal-title":"Rheumatology"},{"key":"10.1007\/s12350-021-02838-w_bib120","doi-asserted-by":"crossref","DOI":"10.1677\/joe.1.06082","article-title":"Somatostatin receptor subtype expression in the human heart: Differential expression by myocytes and fibroblasts","author":"Smith","year":"2005","journal-title":"J Endocrinol"},{"key":"10.1007\/s12350-021-02838-w_bib121","article-title":"Cell proliferation detected using [18F]FLT PET\/CT as an early marker of abdominal aortic aneurysm","author":"Gandhi","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02838-w_bib122","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejca.2015.11.018","article-title":"A systematic review on [18F]FLT-PET uptake as a measure of treatment response in cancer patients","volume":"55","author":"Bollineni","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1007\/s12350-021-02838-w_bib123","article-title":"Dissecting the target leukocyte subpopulations of clinically relevant inflammation radiopharmaceuticals","author":"Borchert","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02838-w_bib124","doi-asserted-by":"crossref","DOI":"10.7150\/thno.11251","article-title":"Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging","author":"Wester","year":"2015","journal-title":"Theranostics"},{"key":"10.1007\/s12350-021-02838-w_bib125","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004019","article-title":"Myocardial immunocompetent cells and macrophage phenotypes as histopathological surrogates for diagnosis of cardiac sarcoidosis in Japanese","author":"Honda","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1007\/s12350-021-02838-w_bib126","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/537929","article-title":"Different activity of the biological axis VEGF-Flt-1 (fms-like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: A bronchoalveolar lavage study","author":"Antoniou","year":"2009","journal-title":"Clin Dev Immunol"},{"key":"10.1007\/s12350-021-02838-w_bib127","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3390\/biom10121629","article-title":"[68Ga]Ga-pentixafor for pet imaging of vascular expression of CXCR-4 as a marker of arterial inflammation in HIV-infected patients: A comparison with18F[FDG] pet imaging","volume":"10","author":"Lawal","year":"2020","journal-title":"Biomolecules"},{"key":"10.1007\/s12350-021-02838-w_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep45061","article-title":"The chemokine receptor CXCR4 promotes granuloma formation by sustaining a mycobacteria-induced angiogenesis programme","volume":"7","author":"Torraca","year":"2017","journal-title":"Sci Rep"},{"key":"10.1007\/s12350-021-02838-w_bib129","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/hupa.2002.129423","article-title":"Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: An immunohistochemical study","volume":"33","author":"Gonz\u00e1lez","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1007\/s12350-021-02838-w_bib130","doi-asserted-by":"crossref","DOI":"10.1136\/thx.2005.051979","article-title":"Matrix metalloproteinases in destructive pulmonary pathology","author":"Elkington","year":"2006","journal-title":"Thorax"},{"key":"10.1007\/s12350-021-02838-w_bib131","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1053\/j.semnuclmed.2014.10.006","article-title":"F-18 fluoromisonidazole for imaging tumor hypoxia: Imaging the microenvironment for personalized cancer therapy","volume":"45","author":"Rajendran","year":"2015","journal-title":"Semin Nucl Med"},{"key":"10.1007\/s12350-021-02838-w_bib132","doi-asserted-by":"crossref","DOI":"10.1007\/5584_2015_144","article-title":"Expression of Hif-1A\/VEGF\/ING-4 axis in pulmonary sarcoidosis","author":"Piotrowski","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"10.1007\/s12350-021-02838-w_bib133","first-page":"1186","article-title":"A machine learning-based parametric imaging algorithm for noninvasive quantification of dynamic [68Ga]DOTATATE PET-CT","volume":"60","author":"Zhou","year":"2019","journal-title":"J Nucl Med"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-021-02838-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-021-02838-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123005871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123005871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-021-02838-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:11:17Z","timestamp":1761027077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123005871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":133,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1071358123005871"],"URL":"https:\/\/doi.org\/10.1007\/s12350-021-02838-w","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential novel imaging targets of inflammation in cardiac sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-021-02838-w","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}